Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $286,434 | 1 | 77.7% |
| Consulting Fee | $82,250 | 7 | 22.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ALCRESTA THERAPEUTICS, INC. | $366,434 | 6 | $0 (2022) |
| Endogastric Solutions, Inc | $2,250 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $326,434 | 2 | ALCRESTA THERAPEUTICS, INC. ($326,434) |
| 2021 | $40,000 | 4 | ALCRESTA THERAPEUTICS, INC. ($40,000) |
| 2020 | $2,250 | 2 | Endogastric Solutions, Inc ($2,250) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/03/2022 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $286,434.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/03/2022 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2021 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/01/2021 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/01/2021 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/01/2021 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/06/2020 | Endogastric Solutions, Inc | ESOPHYX (Device) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: GERD | ||||||
| 01/09/2020 | Endogastric Solutions, Inc | ESOPHYX (Device) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: GERD | ||||||
About Dr. Alan Muney, M.D
Dr. Alan Muney, M.D is a Pediatrics healthcare provider based in Darien, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1568793644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Muney, M.D has received a total of $368,684 in payments from pharmaceutical and medical device companies, with $326,434 received in 2022. These payments were reported across 8 transactions from 2 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($286,434).
Practice Information
- Specialty Pediatrics
- Location Darien, CT
- Active Since 01/29/2010
- Last Updated 01/29/2010
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568793644
Products in Payments
- RELIZORB (Device) $366,434
- ESOPHYX (Device) $2,250
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Darien
Dr. John Dubaz, M.d, M.D
Pediatrics — Payments: $9,614
Afsoon Karimi, Md, MD
Pediatrics — Payments: $2,881
Dr. Lauren Bader, Md, MD
Pediatrics — Payments: $2,612
Jennifer Hall, M.d, M.D
Pediatrics — Payments: $920.04
Anita Kewalramani, Md, MD
Pediatrics — Payments: $569.89
Robert Davis, D.o, D.O
Pediatrics — Payments: $472.14